# Shrare

> Shrare is an AI-powered platform that transforms unexploited academic research into ready-to-license rare disease therapies, connecting the world of science with the world of patients.

Shrare bridges the gap between academic researchers with promising rare disease discoveries and pharmaceutical companies seeking de-risked, clinical-stage assets to license.

## Key Pages

- [Home](https://www.shrare.ai/): Overview of Shrare's mission and platform
- [For Researchers](https://www.shrare.ai/researchers): How Shrare helps researchers commercialize rare disease discoveries
- [For Pharma](https://www.shrare.ai/pharma): How pharma companies can license de-risked rare disease assets
- [Technology](https://www.shrare.ai/technology): How Shrare's AI platform transforms research into therapies
- [About](https://www.shrare.ai/about): Team, mission, and company background
- [News](https://www.shrare.ai/news): Latest company updates and milestones
- [Full Details](https://www.shrare.ai/llms-full.txt): Comprehensive information about Shrare

## Contact

- Website: https://www.shrare.ai
- Contact: https://www.shrare.ai/about#contact